Although the results did not reach statistical significance, it was observed that the patients in the high-risk group exhibited lower levels of TMB compared to those in the low-risk group.
← all excerpts
A random survival forest-based pathomics signature classifies immunotherapy prognosis and profiles TIME and genomics in ES-SCLC patients.
1
—
—